Hoba Therapeutics Raises EUR 23 Million in Series A Financing for Innovative Neuropathic Pain Treatment
-
Drug News
Hoba Therapeutics Raises EUR 23 Million in Series A Financing for Innovative Neuropathic Pain Treatment
Danish biotech company, Hoba Therapeutics, has successfully secured EUR 23 million (USD 25 million) in a Series A financing first…
Read More »
